3-N-[3-fluoro-2-(morpholin-4-ylmethyl)phenyl]-2-methyl-6-morpholin-4-ylimidazo[1,2-b]pyridazine-3,8-diamine
C22H28FN7O2 — CID 121426179
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-N-[3-fluoro-2-(morpholin-4-ylmethyl)phenyl]-2-methyl-6-morpholin-4-ylimidazo[1,2-b]pyridazine-3,8-diamine
3-N-[3-fluoro-2-(morpholin-4-ylmethyl)phenyl]-2-methyl-6-morpholin-4-ylimidazo[1,2-b]pyridazine-3,8-diamine (PubChem CID 121426179) has the molecular formula C22H28FN7O2 and a molecular weight of 441.51 g/mol. Its IUPAC name is 3-N-[3-fluoro-2-(morpholin-4-ylmethyl)phenyl]-2-methyl-6-morpholin-4-ylimidazo[1,2-b]pyridazine-3,8-diamine.
Molecular Properties
| Compound Name | 3-N-[3-fluoro-2-(morpholin-4-ylmethyl)phenyl]-2-methyl-6-morpholin-4-ylimidazo[1,2-b]pyridazine-3,8-diamine |
|---|---|
| PubChem CID | 121426179 |
| Molecular Formula | C22H28FN7O2 |
| Molecular Weight | 441.51 g/mol |
| Exact Mass | 441.23 |
| IUPAC Name | 3-N-[3-fluoro-2-(morpholin-4-ylmethyl)phenyl]-2-methyl-6-morpholin-4-ylimidazo[1,2-b]pyridazine-3,8-diamine |
| SMILES | Cc1nc2c(N)cc(N3CCOCC3)nn2c1Nc1cccc(F)c1CN1CCOCC1 |
| InChI | InChI=1S/C22H28FN7O2/c1-15-21(26-19-4-2-3-17(23)16(19)14-28-5-9-31-10-6-28)30-22(25-15)18(24)13-20(27-30)29-7-11-32-12-8-29/h2-4,13,26H,5-12,14,24H2,1H3 |
| InChIKey | RBPFGYWBLYMGNQ-UHFFFAOYSA-N |
| XLogP | 2.17 |
| TPSA | 93.18 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 441.51 |
| LogP ≤ 5 | 2.17 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121426179 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.